• 1
    Ege, M. J., Mayer, M., Normand, A. C., Genuneit, J., Cookson, W. O., Braun-Fahrlander, C., Heederik, D. et al., Exposure to environmental microorganisms and childhood asthma. N. Engl. J. Med. 2011. 364: 701709.
  • 2
    North, M. L. and Ellis, A. K., The role of epigenetics in the developmental origins of allergic disease. Ann. Allergy Asthma Immunol. 2011. 106: 355361; quiz 362.
  • 3
    March, M. E., Sleiman, P. M. and Hakonarson, H., The genetics of asthma and allergic disorders. Discov. Med. 2011. 11: 3545.
  • 4
    Minnicozzi, M., Sawyer, R. T. and Fenton, M. J., Innate immunity in allergic disease. Immunol. Rev. 2011. 242: 106127.
  • 5
    Platts-Mills, T. A. and Woodfolk, J. A., Allergens and their role in the allergic immune response. Immunol. Rev. 2011. 242: 5168.
  • 6
    Valerio, C. R., Murray, P., Arlian, L. G. and Slater, J. E., Bacterial 16S ribosomal DNA in house dust mite cultures. J. Allergy Clin. Immunol. 2005. 116: 12961300.
  • 7
    Douwes, J., Siebers, R., Wouters, I., Doekes, G., Fitzharris, P. and Crane, J., Endotoxin, (1 –> 3)-beta-D-glucans and fungal extra-cellular polysaccharides in New Zealand homes: a pilot study. Ann. Agric. Environ. Med. 2006. 13: 361365.
  • 8
    Gregory, L. G. and Lloyd, C. M., Orchestrating house dust mite-associated allergy in the lung. Trends Immunol. 2011. 32: 402411.
  • 9
    Shreffler, W. G., Castro, R. R., Kucuk, Z. Y., Charlop-Powers, Z., Grishina, G., Yoo, S., Burks, A. W. et al., The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J. Immunol. 2006. 177: 36773685.
  • 10
    Gilles, S., Fekete, A., Zhang, X., Beck, I., Blume, C., Ring, J., Schmidt-Weber, C. et al., Pollen metabolome analysis reveals adenosine as a major regulator of dendritic cell-primed TH cell responses. J. Allergy Clin. Immunol. 2011. 127: 454461.
  • 11
    Traidl-Hoffmann, C., Mariani, V., Hochrein, H., Karg, K., Wagner, H., Ring, J., Mueller, M. J. et al., Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J. Exp. Med. 2005. 201: 627636.
  • 12
    Eisenbarth, S. C., Piggott, D. A., Huleatt, J. W., Visintin, I., Herrick, C. A. and Bottomly, K., Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 2002. 196: 16451651.
  • 13
    Simpson, A. and Martinez, F. D., The role of lipopolysaccharide in the development of atopy in humans. Clin. Exp. Allergy 2010. 40: 209223.
  • 14
    Spiewak, R., Skorska, C., Prazmo, Z. and Dutkiewicz, J., Bacterial endotoxin associated with pollen as a potential factor aggravating pollinosis. Ann. Agric. Environ. Med. 1996. 3: 5769.
  • 15
    Casale, T. B. and Stokes, J. R., Future forms of immunotherapy. J. Allergy Clin. Immunol. 2011. 127: 815; quiz 16–17.
  • 16
    Trivedi, B., Valerio, C. and Slater, J. E., Endotoxin content of standardized allergen vaccines. J. Allergy Clin. Immunol. 2003. 111: 777783.
  • 17
    Williams, L. K., Ownby, D. R., Maliarik, M. J. and Johnson, C. C., The role of endotoxin and its receptors in allergic disease. Ann. Allergy Asthma Immunol. 2005. 94: 323332.
  • 18
    Suck, R. and Cromwell, O., Quality control of recombinant pollen allergens. Curr. Pharm. Anal. 2006. 2: 249257.
  • 19
    Araujo, M. I., Campos, R. A., Cardoso, L. S., Oliveira, S. C. and Carvalho, E. M., Immunomodulation of the allergic inflammatory response: new developments. Inflamm. Allergy Drug Targets 2010. 9: 7382.
  • 20
    Mittag, D., Scholzen, A., Varese, N., Baxter, L., Paukovics, G., Harrison, L. C., Rolland, J. M. et al., The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells. J. Immunol. 2010. 184: 47084716.
  • 21
    O'Hehir, R. E., Gardner, L. M., de Leon, M. P., Hales, B. J., Biondo, M., Douglass, J. A., Rolland, J. M. et al., House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am. J. Respir Crit. Care Med. 2009. 180: 936947.
  • 22
    Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E. and Roncarolo, M. G., A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997. 389: 737742.
  • 23
    Hawrylowicz, C. M. and O'Garra, A., Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 2005. 5: 271283.
  • 24
    Matricardi, P. M., Bjorksten, B., Bonini, S., Bousquet, J., Djukanovic, R., Dreborg, S., Gereda, J. et al., Microbial products in allergy prevention and therapy. Allergy 2003. 58: 461471.
  • 25
    Wang, Y. and Wills-Karp, M., The potential role of interleukin-17 in severe asthma. Curr. Allergy Asthma Rep. 2011. 11: 388394.
  • 26
    Maione, F., Paschalidis, N., Mascolo, N., Dufton, N., Perretti, M. and D'Aquisto, F., Interleukin-17 sustains rather than induces inflammation. Biochem. Pharmacol. 2008. 77: 878887.
  • 27
    Jankovic, D., Kullberg, M. C., Feng, C. G., Goldszmid, R. S., Collazo, C. M., Wilson, M., Wynn, T. A. et al., Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 2007. 204: 273283.
  • 28
    Duan, W., Takanori, S. and Croft, M., Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+ T regulatory cells. J. Immunol. 2008. 181: 86508659.
  • 29
    Re, F. and Strominger, J., Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 2001. 276: 3769237699.
  • 30
    Ferwerda, G., Meyer-Wentrup, F., Kullberg, B. J., Netea, M. G. and Adema, G. J., Dectin-1 synergises with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol. 2008. 10: 20582066.
  • 31
    Tesse, R., Pandey, R. C. and Kabesch, M., Genetic variations in toll-like receptor pathway genes influence asthma and atopy. Allergy 2010. 66: 307316.
  • 32
    de Leon, M. P., Glaspole, I. N., Drew, A. C., Rolland, J. M., O'Hehir, R. E. and Suphioglu, C., Immunological analysis of allergenic cross-reactivity between peanut and tree nuts. Clin. Exp. Allergy 2003. 33: 12731280.
  • 33
    Maecker, H. T., Moon, J., Bhatia, S., Ghanekar, S. A., Maino, V. C., Payne, J. K., Kuus-Reichel, K. et al., Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunol. 2005. 6: 17.
  • 34
    Hume, D. A., Underhill, D. M., Sweet, M. J., Ozinsky, A. O., Liew, F. Y. and Aderem, A., Macrophages exposed continuously to lipopolysaccharide and other agonists that act vial toll-like receptors exhibit a sustained and additive activation state. BMC Immunol. 2001. 2: 1122.
  • 35
    Mansell, A., Smith, R., Doyle, S. L., Gray, P., Fenner, J. E., Crack, P. J., Nicholson, S. E. et al., Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 2006. 7: 148155.
  • 36
    Verstak, B., Nagpal, K., Bottomley, S. P., Golenbock, D. T., Hertzog, P. J. and Mansell, A., MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J. Biol. Chem. 2009. 284: 2419224203.